Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells

Br J Pharmacol. 2008 Apr;153(7):1420-31. doi: 10.1038/bjp.2008.25. Epub 2008 Feb 18.

Abstract

Background and purpose: The factors that influence the cellular levels of endothelin-1 (ET-1) include transcription, mRNA localization, stability and translation, post-translational maturation of preproET-1 and degradation of ET-1. We investigated the regulation of ET-1 mRNA abundance by extracellular ET-1 in porcine aortic endothelial cells (PAECs).

Experimental approach: Passsage one cultures of PAECs were incubated in starving medium in the presence or absence of ET-1 and antagonists or pharmacological inhibitors. PreproET-1 mRNA, endothelin-1 promoter activity, Erk and p38 MAPK activation were determined.

Key results: Exogenous ET-1 reduced cellular ET-1 mRNA content: a reduction of 10 000-fold was observed after 4 h. ET-1 simultaneously reduced the stability of ET-1 mRNA and increased the loading of RNA Polymerase II at the endothelin-1 promoter. In the absence of exogenous ET-1, the ETB-selective antagonist, BQ788, increased ET-1 mRNA. An ETA-selective antagonist had no effect. ET-1 mRNA returned to control levels within 24 h. Whereas activation of p38 MAPK induced by ET-1 peaked at 30 min and returned to control levels within 90 min, Erk1/2 remained active after 4 h of stimulation. Inhibition of p38 MAPK prevented the ET-1-induced decrease in ET-1 mRNA. In contrast, Erk1/2 inhibition increased ET-1 mRNA. Similarly, inhibition of receptor internalization increased ET-1 mRNA in the presence or absence of exogenous ET-1.

Conclusions and implications: These results suggest that extracellular ET-1 regulates the abundance of ET-1 mRNA in PAECs, in an ETB receptor-dependent manner, by modulating both mRNA stability and transcription via mechanisms involving receptor endocytosis and both ERK and p38 MAPK pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / metabolism
  • Endocytosis / physiology
  • Endothelial Cells / metabolism
  • Endothelin-1 / metabolism*
  • Endothelin-1 / pharmacology
  • Endothelium, Vascular / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • RNA Polymerase II / metabolism
  • RNA Stability / physiology
  • RNA, Messenger / metabolism*
  • Receptor, Endothelin B / metabolism*
  • Swine
  • Time Factors
  • Transcription, Genetic / physiology
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Endothelin-1
  • RNA, Messenger
  • Receptor, Endothelin B
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases
  • RNA Polymerase II

Grants and funding